How anti-c in a D- patient prompted lifesaving work between a transfusion service and a blood center reference laboratory
- PMID: 38910443
- DOI: 10.2478/immunohematology-2024-011
How anti-c in a D- patient prompted lifesaving work between a transfusion service and a blood center reference laboratory
Abstract
This case report showcases an extraordinary collaboration to support the transfusion needs of a patient with a rare phenotype and long-standing anemia due to gastrointestinal bleeding. This report describes the Immunohematology Reference Laboratory testing and logistics of rare blood provision over an 11-year period, as well as a summary of the hematologic, gastroenterologic, and surgical interventions. This case illustrates how a strong collaboration among the clinical team, laboratory, blood center, and the rare donor community facilitated successful management of this patient's anemia until the patient could receive life-changing treatment.
Keywords: American Rare Donor Program; rare blood; red blood cell alloimmunization.
© 2024 Gavin Patch et al., published by Sciendo.
References
-
- Nance S, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.
-
- Meny GM, Flickinger C, Marcucci CJ. The American Rare Donor Program. Crit Care 2013;28:110.e9–18. doi:10.1016/j.jcrc.2012.02.017.
-
- Keller MA, Nance ST, Kavitsky V et al. The American Rare Donor Program: twenty-five years supporting rare blood needs. Immunohematology In press.
-
- Maurer J, Nance S, Kavitsky V, Facey D, Keller M. High prevalence antigen negative unit requests: what if it includes being O negative? Transfusion 2021;35(Suppl 3):159–60A.
-
- Maurer J, Nance S, Kavitsky V, Facey D, Keller M . When rare blood goes overseas. Transfusion 2021;35(Suppl 3):80A.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical